165 related articles for article (PubMed ID: 2949057)
1. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.
Saletu B; Grünberger J; Linzmayer L
J Neural Transm; 1986; 67(3-4):241-66. PubMed ID: 2949057
[TBL] [Abstract][Full Text] [Related]
2. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects.
Saletu B; Grünberger J
J Clin Psychiatry; 1988 Aug; 49 Suppl():59-71. PubMed ID: 2970456
[TBL] [Abstract][Full Text] [Related]
3. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
Saletu B; Grünberger J; Rajna P; Karobath M
J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
[TBL] [Abstract][Full Text] [Related]
4. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L; Stöhr H
Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
[TBL] [Abstract][Full Text] [Related]
5. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
[TBL] [Abstract][Full Text] [Related]
6. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L; Anderer P
Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
[TBL] [Abstract][Full Text] [Related]
7. Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.
Saletu B; Grünberger J; Linzmayer L
Arch Gerontol Geriatr; 1986 Oct; 5(3):165-81. PubMed ID: 3541816
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
[TBL] [Abstract][Full Text] [Related]
9. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
[TBL] [Abstract][Full Text] [Related]
10. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
[TBL] [Abstract][Full Text] [Related]
11. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
Saletu B; Grünberger J; Cepko H
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
Saletu B; Grünberger J; Anderer P; Linzmayer L; Semlitsch HV; Magni G
Br J Clin Pharmacol; 1992 Jun; 33(6):589-601. PubMed ID: 1389931
[TBL] [Abstract][Full Text] [Related]
13. Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses.
Saletu B; Grünberger J
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):45-52. PubMed ID: 3882681
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):362-73. PubMed ID: 3525428
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
16. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L; Wittek R
Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
[TBL] [Abstract][Full Text] [Related]
17. Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.
Saletu B; Barbanoj MJ; Anderer P; Sieghart W; Grünberger J
Methods Find Exp Clin Pharmacol; 1993 Jun; 15(5):291-312. PubMed ID: 8412414
[TBL] [Abstract][Full Text] [Related]
18. Quantitative EEG and psychometric analyses in assessing CNS-activity of Ro 13-5057--a cerebral insufficiency improver.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):269-85. PubMed ID: 6927816
[TBL] [Abstract][Full Text] [Related]
19. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
[TBL] [Abstract][Full Text] [Related]
20. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
